Avalyn Pharma Inc. (AVLN) Short Interest
Nasdaq • AVLN • US05348Y1055
As of Oct 22, 2026, ORTEX estimated 9.4% of free float sold short, 7.4 days to cover, cost to borrow 1.87%. Sign up for live short interest data.
Nasdaq • AVLN • US05348Y1055
As of Oct 22, 2026, ORTEX estimated 9.4% of free float sold short, 7.4 days to cover, cost to borrow 1.87%. Sign up for live short interest data.
This page tracks how heavily Avalyn Pharma Inc. (Nasdaq:AVLN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Avalyn Pharma Inc. (Nasdaq: AVLN) has a market capitalization of $1.29B. Last close $29.15 (as of 2026-11-09); 52-week range $22.24 to $40.17. ORTEX data as of 2026-10-22: short interest was 9.4% of free float, 7.4 days to cover and the average cost to borrow was 1.87%. Sign up for live short interest data.